MT1G and renal cell carcinoma: Even though the role of MTs in ferroptosis is not fully understood, one of its subtypes – MT-1G – was found to negatively regulate ferroptosis in hepatocellular and renal cell carcinomas and to facilitate resistance to sorafenib treatment [54,55].